Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

March 7, 2016

Our paper “Mutant Calreticulin Requires Both its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation” gets published in Cancer Discovery!

previous post: Dr. Shannon Elf presents a Late Breaking Abstract at the Annual ASH Conference
next post: Ann Mullally receives Clinical Investigator Continuation Grant